Key result
Neuromuscular electrical stimulation improves walking distance by ~70 meters in acute heart failure.
Why the study?
Exercise-based rehabilitation benefits chronic heart failure, but its feasibility in acute heart failure is limited, making neuromuscular electrical stimulation a potential alternative.
Does neuromuscular electrical stimulation improve 6-minute walking distance in hospitalized patients with acute heart failure?
Meta-Analysis (n=256)
Does neuromuscular electrical stimulation improve 6-minute walking distance in hospitalized patients with acute heart failure?
Neuromuscular electrical stimulation is a safe, short-term bridge therapy that significantly improves functional capacity and quality of life in hospitalized patients with acute heart failure who may be unable to engage in conventional rehabilitation.
Answers are grounded in this paper and cite their sources.
Supports NMES as bridge therapy in acute HF inpatients; extends chronic HF rehabilitation evidence to the acute phase.
Background Acute heart failure often leads to impaired physical function, high rehospitalization rates, and poor quality of life. Although exercise-based rehabilitation benefits chronic heart failure patients, its feasibility in acute heart failure is limited. Neuromuscular electrical stimulation offers a potential alternative by safely inducing muscle contractions without causing dyspnea. Methods The protocol was registered with the International Prospective Register of Systematic Reviews (registration number CRD42023453116). Following PRISMA guidelines, a comprehensive search of PubMed, Cochrane Library, and Embase was conducted up to October 13, 2025. Randomized controlled trials comparing neuromuscular electrical stimulation to control treatments in patients with acute heart failure were included. Data synthesis was performed using Review Manager 5.4. Results Seven randomized controlled trials, with methodological quality ranging from fair to excellent (Physiotherapy Evidence Database (PEDro) scores 5–9), were included. Pooled data analysis revealed that neuromuscular electrical stimulation significantly improved 6-min walking distance (mean difference = 69.92 m, 95% confidence interval CI [32.17–1 07.68], p = 0.0003), quality of life (standardized mean difference = 1.53, 95% CI [1.03–2.03], p < 0.00001), and showed preliminary evidence of improvement in leg muscle strength (standardized mean difference = 0.77, 95% CI [0.25–1.29], p = 0.004), whereas no significant difference was observed in left ventricular ejection fraction (mean difference = 1.94%, 95% CI [−3.91 to 7.79], p = 0.52). Neuromuscular electrical stimulation was generally well tolerated, with no serious adverse events directly attributable to the intervention. Conclusion Neuromuscular electrical stimulation was noted to be effective for improving physical capacity and quality of life in patients with acute heart failure. It offers a promising option for patients unable to engage in conventional rehabilitation. Further large-scale, multicenter Randomized Controlled Trials (RCTs) are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted a meta-analysis in Acute heart failure (n=256). Neuromuscular electrical stimulation vs. Control treatments (early conventional rehabilitation, usual care, or sham) was evaluated on 6-min walking distance (6MWD) (MD 69.92 m, 95% CI 32.17-107.68, p=0.0003). Neuromuscular electrical stimulation improved 6-minute walking distance by a mean difference of 69.92 meters compared to control treatments in patients with acute heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: